Proceedings 2019Proceedings 2019
Menu

AIOC 2019, Indore

  • Home
  • Instruction Courses
  • Free Papers
  • E-Posters
  • Film Festival
  • Physical Posters
  • Poster Podium Presentations
  • Invited Sessions
  • Hyde Park
  • Pre-Conference Sessions
  • Communication

FP1496 : Role of MDM2 SNP309 gene mutation in pterygium

  1. Home
  2. /
  3. Poster Podium Presentation
  4. /
  5. Ocular Pathology / Ocular...
  6. /
  7. FP1496 : Role of...

FP1496 : Role of MDM2 SNP309 gene mutation in pterygium

Share this post

Dr.Pawan Prasher, P10480

Aim: To study the association between MDM2 SNP309 mutation and pterygium

Methods: In the present study, 37 pterygium patients and 49 controls were screened for MDM2 SNP309 mutation. Peripheral venous blood samples were collected from the study participants and the genomic DNA was isolated. This genomic DNA was used for polymerase chain reaction (PCR) amplification of MDM2 SNP309 mutation using the following set of primers: forward 5’-CGGGAGTTCAGGGTAAAGG-3’ and reverse 5’-TCGGAACGTGTCTGAACTTG-3’.

Results: In the pterygium group, the frequency of genotypes GG, GT and TT were 32.65%, 40.81% and 26.53%; whereas in the controls it was 27.07%, 35.13% and 37.83% respectively. There was no statistically significant difference between the two groups in the genotype frequency of MDM2 SNP309 polymorphism (p>0.05).

Conclusions: The results show no significant difference between the ptergyium patients and controls in the genotype frequency of MDM2 SNP309 polymorphism.

Share on FacebookShare on TwitterShare on Linkedin

Leave a Comment Cancel Reply

Read next article ...

FP21 : Evaluation of Barrett’s Universal II Formula in Indian Eyes.

Read previous article ...

FP1526-Vitreo Retinal Diseases - IV -Determination and validation of retinal arteriolar and venular calibre measurements using cSLO-HRA.
Close